Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in diabetic nephropathy.

Sally M Marshall1

  • 1The Medical School, University of Newcastle upon Tyne. s.m.marshall@ncl.ac.uk

Clinical Medicine (London, England)
|July 13, 2004
PubMed
Summary

Diabetic nephropathy, a leading cause of kidney failure, involves podocyte damage and proteinuria. Effective management of glucose, blood pressure, and cardiovascular risk factors can prevent progression and delay renal replacement therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of statins and ACE inhibitors on the metabolome in the Adolescent Type 1 Diabetes cardio-renal Intervention Trial (AdDIT) cohort.

Scientific reports·2026
Same author

Socioeconomic representativeness of Australian, Canadian and British cohorts from the paediatric diabetes AdDIT study: comparisons to regional and national data.

BMC medicine·2023
Same author

Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohort.

Diabetologia·2022
Same author

Celebrating 100 years of insulin.

Diabetologia·2021
Same author

Metabolic consequences of obesity and type 2 diabetes: Balancing genes and environment for personalized care.

Cell·2021
Same author

Vascular Effects of ACE (Angiotensin-Converting Enzyme) Inhibitors and Statins in Adolescents With Type 1 Diabetes.

Hypertension (Dallas, Tex. : 1979)·2020

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiology

Background:

  • Diabetic nephropathy is the primary cause of end-stage renal disease globally, predominantly in type 2 diabetes patients.
  • Cardiovascular risk escalates with diabetic nephropathy progression.
  • Podocyte injury, characterized by foot process effacement and nephrin loss, contributes to proteinuria.

Purpose of the Study:

  • To review the pathogenesis of diabetic nephropathy, focusing on podocyte involvement.
  • To outline strategies for preventing and managing diabetic nephropathy.
  • To emphasize the importance of controlling cardiovascular risk factors.

Main Methods:

  • Review of current literature on diabetic nephropathy pathogenesis and management.
  • Analysis of the role of podocyte injury in disease progression.
  • Evaluation of therapeutic strategies including glucose control, blood pressure management, and renin-angiotensin system inhibition.

Main Results:

  • Podocyte structural and functional changes, including broadening and effacement of foot processes and loss of podocyte-specific proteins like nephrin, are key features.
  • Proteinuria is linked to these podocyte alterations and eventual podocyte loss.
  • Good glycemic and blood pressure control can prevent nephropathy development.

Conclusions:

  • Preventing diabetic nephropathy hinges on optimal glucose and blood pressure management.
  • In patients with microalbuminuria or proteinuria, controlling intraglomerular pressure and systemic blood pressure is crucial for delaying renal replacement therapy.
  • Aggressive management of cardiovascular risk factors is essential for slowing nephropathy progression and preventing cardiovascular events.

Related Experiment Videos